Long-term prospects looking good for MS patients

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1634, 2008-01, pp. : 9-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lopinavir/ritonavir long-term therapy good value for treatment-naive patients

Inpharma, Vol. 1, Iss. 1367, 2002-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Lopinavir/ritonavir long-term therapy good value for treatment-naive patients

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 392, 2002-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Interferons in MS: long-term clinical benefit uncertain

Inpharma, Vol. 1, Iss. 1375, 2003-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

An Inventory of Short Term and Long Term Changes in Gene Expression Under Interferon β Treatment of Relapsing Remitting MS Patients

Current Pharmaceutical Design, Vol. 18, Iss. 29, 2012-10 ,pp. : 4475-4484

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetics of Valsartan in Hypertensive Patients on Long-Term Haemodialysis

By Leidig M.F.

Clinical Drug Investigation, Vol. 21, Iss. 1, 2001-01 ,pp. : 59-66

Adis International

Access to resources Recommend Favorite